Clearbridge Investments, LLC Bluebird Bio, Inc. Transaction History

Clearbridge Investments, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$34.44 - $43.75 $12,467 - $15,837	-362 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$27.12 - $45.97 $14,807 - $25,099	-546 Reduced 60.13%	362 $22,000
Q1 2020 May 15, 2020	BUY	$26.16 - $63.5 $6,383 - $15,494	244 Added 36.75%	908 $42,000
Q4 2019 Feb 14, 2020	SELL	$46.96 - $61.67 $21,836 - $28,676	-465 Reduced 41.19%	664 $57,000
Q2 2019 Aug 14, 2019	BUY	$75.84 - $105.21 $21,993 - $30,510	290 Added 34.56%	1,129 $0
Q1 2019 May 15, 2019	BUY	$64.44 - $104.11 $8,312 - $13,430	129 Added 18.17%	839 $132,000
Q2 2018 Aug 14, 2018	SELL	$99.64 - $127.59 $17,237 - $22,073	-173 Reduced 19.59%	710 $111,000
Q4 2017 Feb 14, 2018	SELL	$81.25 - $130.7 $9,993 - $16,076	-123 Reduced 12.23%	883 $157,000
Q2 2017 Aug 14, 2017	BUY	N/A	1,006	1,006 $106,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Clearbridge Investments, LLC with notifications on news.